TOMI Environmental Solutions, Inc. has received formal approval from four additional EU member states for its Binary Ionization Technology (BIT), a non-thermal plasma-based disinfection system. The technology is now approved in Belgium, Denmark, Germany, and Hungary, in addition to the Netherlands, Great Britain, and Northern Ireland.
Overview
The Binary Ionization Technology Solution has been authorized as a PT2 disinfectant for both SteraMist room fogging and surface spraying equipment. It is approved for professional indoor use, addressing bacteria, yeasts, and mycobacteria in various sectors, including medical, healthcare, industrial, commercial, hospitality, institutional, and tertiary.
What it does
The BIT solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP). This produces a germ-killing aerosol, represented by the SteraMist brand of products. TOMI products are designed to service a broad spectrum of commercial structures, including hospitals, offices, hotels, schools, and restaurants.
The approval was granted under the European Union's Biocidal Products Regulation (BPR), which governs the authorization of biocidal products across all EU member states. This approval is expected to support a streamlined mutual recognition pathway in other EU member states, potentially accelerating TOMI's ability to bring BIT to market across the broader European Union.
Tradeoffs
The expansion of TOMI's Binary Ionization Technology into additional EU member states is expected to drive sales and deliver greater value to shareholders. However, the company's ability to acquire new customers and expand sales is subject to various risks and uncertainties, including general business and economic conditions.
In conclusion, TOMI Environmental Solutions' Binary Ionization Technology has received formal approval in four additional EU member states, expanding its presence in the European market. The technology's growing acceptance in Europe is expected to drive sales and deliver greater value to shareholders, but the company's success is subject to various risks and uncertainties.